COPYRIGHT© Jilin Zixin Pharmaceutical Industrial Co.,Ltd.

COPYRIGHT© 2018  吉林紫鑫药业股份有限公司

Jilin Zixin Pharmaceutical Co., Ltd. 2013 First Quarter Results Announcement

Page view

Stock code: 002118 Securities abbreviation: Zixin Pharmaceutical Announcement No.: 2013-009

Jilin Zixin Pharmaceutical Co., Ltd. 2013 First Quarter Results Announcement

 

The company and all members of the board of directors guarantee that the content of the information disclosure is true, accurate and complete, and there are no false records, misleading statements or major omissions.

   

I. Estimated performance of the current period

1. Performance forecast period: January-March 2013

2. Expected performance: rising in the same direction

 

 project

This reporting period

last year

Net profit attributable to shareholders of listed companies

Increase over the same period of the previous year: 68.25%-116.33%

Profit: 8.3208 million yuan

Profit: 14 million - 18 million

 

Second, the performance forecast pre-audit situation

This performance forecast has not been pre-audited by the CPA.

 

Third, the reasons for changes in performance

The main reason for the expected increase in performance is that the operating income in the reporting period has increased compared with the same period of the previous year; the second is that the government subsidy is received during the reporting period, which is recognized as the current income; the third is the 2012 cash dividend received by the invested company during the reporting period. , confirmed as current income.

 

Fourth, other relevant instructions

The specific data for the first quarter of 2013 will be disclosed in detail in the company's first quarterly report for 2013. Investors are advised to pay attention to investment risks.

Special announcement

Jilin Zixin Pharmaceutical Co., Ltd. Board of Directors

March 29, 2013